Tejon Ranch Co
TRC NYSE Real Estate Financials FY2016βFY2025
Last close Β· Oct 23, 2026
$16.45
1.0%What Tejon Ranch Co does
No business description yet.
- Legal name
- TEJON RANCH CO
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 19, 2026
- Accession Β· CIK
- 0001628280-26-019685
0000096869
Revenue and margins
Tejon Ranch Co had $49.6M of revenue in fiscal 2025, up 18.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Tejon Ranch Co returned β to shareholders in fiscal 2025. The diluted share count rose 0.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Tejon Ranch Co can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $47.2M | $72.6M | $64.5M | $53.7M | $24.9M |
| Debt incl. finance leases | $57.3M | $50.2M | $47.9M | β | β |
| Net debt / EBITDA | 2.3x | β1.2x | β14.9x | β | β |
| Debt / equity | 0.1x | 0.1x | 0.1x | β | β |
| Current ratio | 4.0x | 6.9x | 6.9x | 4.1x | 4.1x |
| Quick ratio | 3.7x | 6.6x | 6.6x | 3.9x | 3.8x |
| Total assets | $546M | $567M | $578M | $608M | $630M |
| Total liabilities | $89.5M | $89.2M | $94.4M | $119M | $140M |
| Shareholders' equity | $441M | $462M | $468M | $474M | $475M |
| Net debt (β = net cash) | $10.1M | β$22.4M | β$16.5M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 6 / 8 | 6 / 8 | 3 / 8 | 4 / 7 | 5 / 7 | 4 / 9 | 4 / 8 | 5 / 8 |
| Accruals ratio | β1.1% | β2.4% | β1.9% | β1.0% | β3.0% | 0.5% | 1.3% | β1.8% | β2.0% | β1.0% |
| Altman Z'' | 3.84 | 6.10 | 6.12 | 6.13 | 6.07 | 6.28 | 7.03 | 6.55 | 5.24 | 4.37 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $46.0M | $35.3M | $45.6M | $49.5M | $37.8M | β | $79.2M | $44.7M | $41.9M | $49.6M |
| Gross profit | β | β | β | β | β | β | $31.2M | $13.0M | $12.8M | $14.5M |
| Operating income | β$6.8M | β$7.5M | $0.4M | β$1.4M | β$6.7M | β$0.3M | $13.7M | β$3.7M | β$9.2M | β$8.0M |
| Pretax income | $1.3M | β$3.1M | $5.6M | $14.6M | $0.1M | $9.2M | $23.2M | $5.6M | $3.7M | $1.2M |
| Income tax | $0.5M | β$1.3M | $1.3M | $4.0M | $0.8M | $3.8M | $7.4M | $2.3M | $1.0M | $1.1M |
| Net income | $0.8M | β$1.8M | $4.3M | $10.6M | β$0.7M | $5.3M | $15.8M | $3.3M | $2.7M | $0.1M |
| Diluted EPS | $0.04 | β$0.08 | $0.16 | $0.40 | β$0.03 | $0.20 | $0.59 | $0.12 | $0.10 | $0.00 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $5.6M | $9.8M | $14.4M | $16.0M | $15.5M | $2.8M | $8.5M | $13.7M | $14.3M | $6.1M |
| Capital expenditure | $26.4M | $21.7M | $22.6M | $25.2M | $22.3M | $20.9M | $22.6M | $21.3M | $57.2M | β |
| Free cash flow | β$20.8M | β$11.9M | β$8.2M | β$9.2M | β$6.8M | β$18.1M | β$14.1M | β$7.7M | β$42.9M | β |
| Depreciation and amortization | $5.7M | $5.7M | $5.4M | $5.0M | $4.9M | $4.6M | $4.6M | $4.8M | $4.9M | $6.0M |
| Stock-based compensation | $4.6M | $3.6M | $3.2M | $3.2M | $4.5M | $4.3M | $2.9M | $3.3M | $4.2M | $1.7M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.3M | $91.0M | $79.7M | $66.2M | $58.1M | $47.2M | $72.6M | $64.5M | $53.7M | $24.9M |
| Total debt | $85.4M | $74.0M | $69.9M | $66.1M | $61.4M | $57.3M | $50.2M | $47.9M | β | β |
| Current assets | $42.9M | $104M | $96.5M | $82.2M | $68.5M | $63.0M | $83.0M | $79.8M | $69.4M | $39.3M |
| Current liabilities | $18.7M | $10.5M | $16.5M | $15.1M | $12.9M | $15.6M | $12.0M | $11.6M | $16.8M | $9.5M |
| Inventory | $3.1M | $2.5M | $2.6M | $2.8M | $3.0M | $5.7M | $3.4M | $3.5M | $4.0M | $3.3M |
| Property and equipment, net | $46.0M | $45.3M | $46.1M | $45.1M | $46.2M | $50.7M | $53.0M | $54.0M | $56.4M | $59.3M |
| Intangible assets | $29.9M | $28.6M | $27.2M | $25.8M | $24.5M | $23.1M | $21.7M | $20.4M | $19.0M | $17.6M |
| Total assets | $440M | $518M | $529M | $539M | $536M | $546M | $567M | $578M | $608M | $630M |
| Total liabilities | $105M | $91.4M | $94.4M | $93.8M | $91.0M | $89.5M | $89.2M | $94.4M | $119M | $140M |
| Shareholders' equity | $306M | $398M | $419M | $430M | $430M | $441M | $462M | $468M | $474M | $475M |
| Margins | ||||||||||
| Gross margin | β | β | β | β | β | β | 39.4% | 29.1% | 30.5% | 29.2% |
| Operating margin | β14.7% | β21.3% | 1.0% | β2.9% | β17.8% | β | 17.3% | β8.3% | β22.0% | β16.0% |
| EBITDA margin | β2.4% | β5.2% | 12.8% | 7.3% | β4.8% | β | 23.2% | 2.5% | β10.3% | β3.9% |
| Net margin | 1.7% | β5.1% | 9.3% | 21.4% | β2.0% | β | 20.0% | 7.3% | 6.4% | 0.2% |
| FCF margin | β45.2% | β33.7% | β18.0% | β18.5% | β17.9% | β | β17.8% | β17.2% | β102.5% | β |
| Returns | ||||||||||
| Return on capital | β1.1% | β1.6% | 0.1% | β0.2% | β1.0% | β0.0% | 2.1% | β0.5% | β | β |
| Return on capital employed | β1.6% | β1.5% | 0.1% | β0.3% | β1.3% | β0.0% | 2.5% | β0.7% | β1.6% | β1.3% |
| Return on equity | 0.3% | β0.5% | 1.0% | 2.5% | β0.2% | 1.2% | 3.5% | 0.7% | 0.6% | 0.0% |
| Return on assets | 0.2% | β0.4% | 0.8% | 2.0% | β0.1% | 1.0% | 2.8% | 0.6% | 0.5% | 0.0% |
| Return on tangible equity | 0.3% | β0.5% | 1.1% | 2.6% | β0.2% | 1.3% | 3.6% | 0.7% | 0.6% | 0.0% |
| Growth | ||||||||||
| Revenue growth | β | β23.3% | 29.4% | 8.6% | β23.6% | β | β | β43.5% | β6.4% | 18.4% |
| Net income growth | β | β324.6% | β | 148.6% | β107.0% | β | 195.6% | β79.3% | β17.6% | β97.2% |
| EPS growth | β | β300.0% | β | 150.0% | β107.5% | β | 195.0% | β79.7% | β16.7% | β100.0% |
| Share count change | β | 4.5% | 19.6% | 0.7% | 0.8% | 0.3% | 0.9% | 0.2% | 0.4% | 0.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β1.7x | β0.0x | β | 2.3x | β1.2x | β14.9x | β | β |
| Debt / equity | 0.3x | 0.2x | 0.2x | 0.2x | 0.1x | 0.1x | 0.1x | 0.1x | β | β |
| Current ratio | 2.3x | 9.9x | 5.9x | 5.4x | 5.3x | 4.0x | 6.9x | 6.9x | 4.1x | 4.1x |
| Quick ratio | 2.1x | 9.7x | 5.7x | 5.2x | 5.1x | 3.7x | 6.6x | 6.6x | 3.9x | 3.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 57.4% | 61.6% | 49.5% | 50.9% | 58.8% | β | 28.5% | 47.7% | 136.6% | β |
| Stock comp / revenue | 10.0% | 10.1% | 7.1% | 6.5% | 11.9% | β | 3.6% | 7.3% | 10.0% | 3.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 6.0 | 3.0 | 4.0 | 5.0 | 4.0 | 4.0 | 5.0 |
| Altman Z'' | 3.8 | 6.1 | 6.1 | 6.1 | 6.1 | 6.3 | 7.0 | 6.5 | 5.2 | 4.4 |
| Accruals ratio | β1.1% | β2.4% | β1.9% | β1.0% | β3.0% | 0.5% | 1.3% | β1.8% | β2.0% | β1.0% |
Source: SEC EDGAR XBRL filings (CIK 0000096869). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.